Cancer Immunology Research
Cancer Immunology Research
Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. The journal disseminates knowledge of immunology to the cancer research community, catalyzing cross-disciplinary work that yields a deeper understanding of the host-tumor relationship, more potent cancer treatments, and improved clinical outcomes.
Title information
Cancer Immunology Research welcomes submission of original research and review articles to the journal. For descriptions and length requirements of the article types available to submitting authors, see the journal’s Categories of Articles.
The AACR Journals all use a similar Editorial Process and adhere to the same overarching Editorial Policies, both of which are detailed in the Information for Authors. These instructions contain important guidelines on authorship, publishing ethics, availability of materials and data, and data analysis and reporting. Authors should be familiar with these instructions prior to submitting their work to the journal. Manuscripts are stringently reviewed for high standards of scientific merit, and only those that report results of novel, timely, and broadly significant research are accepted for publication.
Editorial oversight of Cancer Immunology Research and decisions on manuscripts submitted to the journal are the responsibility of the Editorial Board with support from journal staff. See Editorial Board for more information.
For detailed metrics about Cancer Immunology Research and the other AACR journals, see AACR Journals Metrics.
Submit your article to Cancer Immunology Research: SmartSubmit.